Early diagnosis and treatment of life-threatening bacterial infections in neonates and critically ill children

  • J. Fischer
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)


In an ideal world specific drugs would effectively kill bacteria without side effects and any risk of selecting resistant strains. These drugs could safely be administered until the patient fully recovers. Bedside tests performed in any symptomatic patient would detect the presence of bacterial infections with the accuracy of HIV testing.


Septic Shock Systemic Inflammatory Response Syndrome Nosocomial Infection Neonatal Sepsis Neisseria Meningitidis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 275:234–240PubMedCrossRefGoogle Scholar
  2. 2.
    Pfaller MA, Herwaldt LA (1997) The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis 25:858–870PubMedCrossRefGoogle Scholar
  3. 3.
    Sebille V, Valleron AJ (1997) A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Comput Biomed Res 30:307–322PubMedCrossRefGoogle Scholar
  4. 4.
    Jaye DL, Waites KB (1997) Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 16:735–747PubMedCrossRefGoogle Scholar
  5. 5.
    Baker MD, Bell LM, Avner JR (1993) Outpatient management without antibiotics of fever in selected infants. N Engl J Med 329:1437–1441PubMedCrossRefGoogle Scholar
  6. 6.
    Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP (1996) Volume of blood required to detect common neonatal pathogens. J Pediatr 129:275–278PubMedCrossRefGoogle Scholar
  7. 7.
    Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M (1996) Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 109:1033–1077PubMedCrossRefGoogle Scholar
  8. 8.
    Hein HA, Ely JW, Lofgren MA (1998) Neonatal respiratory distress in the community hospital: when to transport, when to keep. J Fam Pract 46:284–289PubMedGoogle Scholar
  9. 9.
    Philip AG, Hewitt JR (1980) Early diagnosis of neonatal sepsis. Pediatrics 65:1036–1041PubMedGoogle Scholar
  10. 10.
    Bhutta ZA (1997) Neonatal infections. Curr Opin Pediatr 9:133–140PubMedCrossRefGoogle Scholar
  11. 11.
    Timmermans DR, Sprij AJ, de Bel CE (1996) The discrepancy between daily practice and the policy of a decision-analytic model: the management of fever of unknown origin. Med Decis Making 16:357–366PubMedCrossRefGoogle Scholar
  12. 12.
    Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG et al (1991) Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 91:185S–191SPubMedCrossRefGoogle Scholar
  13. 13.
    Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V (1997) Sepsis in neonates and children: definitions, epidemiology, and outcome. Pediatr Emerg Care 13:277–281PubMedCrossRefGoogle Scholar
  14. 14.
    Merritt WT, Green M (1996) Nosocomial infections in the pediatric intensive care unit. In: Rogers M (ed) Textbook of pediatric intensive care. WB Saunders, New York, pp 975–1001Google Scholar
  15. 15.
    Singh-Naz N, Sprague BM, Patel KM, Pollack MM (1996) Risk factors for nosocomial infection in critically ill children: a prospective cohort study. Crit Care Med 24:875–878PubMedCrossRefGoogle Scholar
  16. 16.
    Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C et al (1996) Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 129:63–71PubMedCrossRefGoogle Scholar
  17. 17.
    Bates DW, Pruess KE, Lee TH (1995) How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 155:593–598PubMedCrossRefGoogle Scholar
  18. 18.
    Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J (1998) Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J 17:10–17PubMedCrossRefGoogle Scholar
  19. 19.
    Shiro H, Muller E, Takeda S, Tosteson TD, Goldmann DA, Pier GB (1995) Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis 171:220–224PubMedCrossRefGoogle Scholar
  20. 20.
    Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R (1990) Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 323:301–308PubMedCrossRefGoogle Scholar
  21. 21.
    Harbarth S, Rutschmann O, Sudre P, Pittet D (1998) Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158:182–189PubMedCrossRefGoogle Scholar
  22. 22.
    Pfaller MA, Jones RN, Doern GV, Kugler K (1998) Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42:1762–1770PubMedGoogle Scholar
  23. 23.
    Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF et al (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474–480PubMedCrossRefGoogle Scholar
  24. 24.
    Goldmann DA, Huskins WC (1997) Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis 24(Suppl 1):S139–145PubMedCrossRefGoogle Scholar
  25. 25.
    Roman RS, Smith J, Walker M, Byrne S, Ramotar K, Dyck B et al (1997) Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis 25:698–705PubMedCrossRefGoogle Scholar
  26. 26.
    Huebner J, Pier GB, Maslow JN, Muller E, Shiro H, Parent M et al (1994) Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis 169:526–531PubMedCrossRefGoogle Scholar
  27. 27.
    Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471–1477PubMedCrossRefGoogle Scholar
  28. 28.
    Bone RC (1996) The sepsis syndrome. Definition and general approach to management. Clin Chest Med 17:175–181PubMedCrossRefGoogle Scholar
  29. 29.
    Tennenberg SD, Weller JJ (1997) Endotoxin-induced, neutrophil-mediated endothelial cytotoxicity is enhanced by T-lymphocytes. J Surg Res 69:11–13PubMedCrossRefGoogle Scholar
  30. 30.
    Kuhns DB, Alvord WG, Gallin JI (1995) Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171:145–152PubMedCrossRefGoogle Scholar
  31. 31.
    Shanley TP, Warner RL, Ward PA (1995) The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1:40–45PubMedCrossRefGoogle Scholar
  32. 32.
    Bone RC (1996) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24:163–172PubMedCrossRefGoogle Scholar
  33. 33.
    Welte K, Gabrilove J, Bronchud M, Platzer E, Morstyn G (1996) Filgastrim (r-metHuGCSF): the first 10 years. Blood 88:1907–1929PubMedGoogle Scholar
  34. 34.
    Kuhns DB, DeCarlo E, Hawk DM, Gallin JI (1992) Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest 89:1734–1740PubMedCrossRefGoogle Scholar
  35. 35.
    Essani NA, Bajt ML, Farhood A, Vonderfecht SL, Jaeschke H (1997) Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 158:5941–5948PubMedGoogle Scholar
  36. 36.
    Mercer-Jones MA, Heinzelmann M, Peyton JC, Wickel D, Cook M, Cheadle WG (1997) Inhibition of neutrophil migration at the site of infection increases remote organ neutrophil sequestration and injury. Shock 8:193–199PubMedCrossRefGoogle Scholar
  37. 37.
    Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680–687PubMedGoogle Scholar
  38. 38.
    Davies MG, Hagen PO (1997) Systemic inflammatory response syndrome. Br J Surg 84:920–935PubMedCrossRefGoogle Scholar
  39. 39.
    Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–243PubMedCrossRefGoogle Scholar
  40. 40.
    Jawaheer G, Neal TJ, Shaw NJ (1997) Blood culture volume and detection of coagulase negative staphylococcal septicaemia in neonates. Arch Dis Child Fetal Neonatal Ed 76:F57–F58PubMedCrossRefGoogle Scholar
  41. 41.
    Laforgia N, Coppola B, Carbone R, Grassi A, Mautone A, Iolascon A (1997) Rapid detection of neonatal sepsis using polymerase chain reaction. Acta Paediatr 86:1097–1099PubMedCrossRefGoogle Scholar
  42. 42.
    Gill EA, Imaizumi T, Carveth H, Topham MK, Tarbet EB, McIntyre TM et al (1998) Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils. FASEB J 12:673–684PubMedGoogle Scholar
  43. 43.
    Chen X, Christou NV (1996) Relative contribution of endothelial cell and polymorphonuclear neutrophil activation in their interactions in systemic inflammatory response syndrome. Arch Surg 131:1148–1154PubMedCrossRefGoogle Scholar
  44. 44.
    Klein NJ, Ison CA, Peakman M, Levin M, Hammerschmidt S, Frosch M et al (1996) The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis 173:172–179PubMedCrossRefGoogle Scholar
  45. 45.
    Bone RC (1996) Why sepsis trials fail. JAMA 276:565–566PubMedCrossRefGoogle Scholar
  46. 46.
    Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658PubMedCrossRefGoogle Scholar
  47. 47.
    Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-lA human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA- lA Sepsis Study Group. N Engl J Med 324:429–436PubMedCrossRefGoogle Scholar
  48. 48.
    Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP et al (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336:912–918PubMedCrossRefGoogle Scholar
  49. 49.
    Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC et al (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697–1702PubMedCrossRefGoogle Scholar
  50. 50.
    Stephenson J (1996) Reflecting and regrouping after failed trials, sepsis researchers forge on. JAMA 275:823–824PubMedCrossRefGoogle Scholar
  51. 51.
    Perez EM, Weisman LE (1997) Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol 24:213–229PubMedGoogle Scholar
  52. 52.
    Kocherlakota P, Gamma EFL (1997) Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 100:E6PubMedCrossRefGoogle Scholar
  53. 53.
    Zenz W, Muntean W, Gallistl S, Zobel G, Grubbauer HM (1995) Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics 96:44–48Google Scholar
  54. 54.
    Giroir BP, Quint PA, Barton P, Kirsch EA, Kitchen L, Goldstein B et al (1997) Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 350:1439–1443PubMedCrossRefGoogle Scholar
  55. 55.
    Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601PubMedCrossRefGoogle Scholar
  56. 56.
    Fischer J, Fanconi S (1996) Systemic inflammatory response syndrome (SIRS) in pediatric patients. In: Tibboel D, van der Voort E (eds) Intensive care in childhood. A challenge to the future. Springer-Verlag, Berlin Heidelberg New York, pp 239–254CrossRefGoogle Scholar
  57. 57.
    Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137–1143PubMedCrossRefGoogle Scholar
  58. 58.
    Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF et al (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26:664–672PubMedCrossRefGoogle Scholar
  59. 59.
    Berger C, Uehlinger J, Ghelfi D, Blau N, Fanconi S (1995) Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia. Eur J Pediatr 154:138–144PubMedCrossRefGoogle Scholar
  60. 60.
    Grant HW, Hadley GP (1997) Prediction of neonatal sepsis by thromboelastography. Pediatr Surg Int 12:289–292PubMedCrossRefGoogle Scholar
  61. 61.
    Charache S, Nelson L, Saw D, Keyser E, Wingfield S (1992) Accuracy and utility of differential white blood cell count in the neonatal intensive care unit. Am J Clin Pathol 97:338–344PubMedGoogle Scholar
  62. 62.
    Schelonka RL, Yoder BA, desJardins SE, Hall RB, Butler J (1994) Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr 125:603–606PubMedCrossRefGoogle Scholar
  63. 63.
    Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W et al (1997) Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 77:F221–F227PubMedCrossRefGoogle Scholar
  64. 64.
    Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R (1998) Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 132:295–299PubMedCrossRefGoogle Scholar
  65. 65.
    Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J et al (1996) Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128:570–573PubMedCrossRefGoogle Scholar
  66. 66.
    Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U (1996) Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 129:574–580PubMedCrossRefGoogle Scholar
  67. 67.
    Kennon C, Overturf G, Bessman S, Sierra E, Smith KJ, Brann B (1996) Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J Pediatr 128:765–769PubMedCrossRefGoogle Scholar
  68. 68.
    Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518PubMedCrossRefGoogle Scholar
  69. 69.
    Archibald LK, Gaynes RP (1997) Hospital-acquired infections in the United States. The importance of interhospital comparisons. Infect Dis Clin North Am 11:245–255PubMedCrossRefGoogle Scholar
  70. 70.
    Bates DW, Cook EF, Goldman L, Lee TH (1990) Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 113:495–500PubMedGoogle Scholar
  71. 71.
    Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS et al (1997) Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 176:1538–1551PubMedCrossRefGoogle Scholar
  72. 72.
    Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM (1996) Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 153:684–693PubMedGoogle Scholar
  73. 73.
    Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA et al (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25:584–599PubMedCrossRefGoogle Scholar
  74. 74.
    Goldmann D, Larson E (1992) Hand-washing and nosocomial infections. N Engl J Med 327:120–122PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • J. Fischer

There are no affiliations available

Personalised recommendations